Lancet Market Size & Share 2023 to 2032
Market Size by Type (Safety Lancets, Standard Lancets, Manually Activated Lancets, Automatically Activated Lancets), by Size (22G and Below, 23G-33G, Above 33G).
Report ID: GMI6239
|
Published Date: July 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Pratiksha Kamthe
Lancet Market Size
Lancet Market size was valued at USD 1.1 billion in 2022 and is estimated to account for USD 1.8 billion by 2032. A lancet is a small, sharp, and pointed surgical instrument or medical device used for pricking or piercing the skin to obtain a blood sample or perform a small incision for medical purposes.
Lancet Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Lancets are typically designed to be disposable and are commonly used in healthcare settings and by individuals for various diagnostic tests, such as blood glucose monitoring with the help of self-monitoring blood glucose device, continuous glucose monitoring, or other diabetes care devices. They are primarily used for obtaining capillary blood samples for analysis, which is less invasive than traditional venous blood sampling methods. The industry is driven by factors such as the growing prevalence of chronic diseases including diabetes, increasing elderly population base, technological advancements, rising remote patient monitoring trend, favorable reimbursement policies, increasing healthcare expenditure, and the growing adoption of point-of-care testing.
For instance, according to the International Diabetes Federation (IDF) Diabetes Atlas, approximately 537 million adults between the ages of 20 and 79 are currently suffering from diabetes. Additionally, by 2030, this number is projected to increase to 643 million, and by 2045, it is anticipated to reach 783 million. As the number of individuals with diabetes continues to rise, the need for lancets for regular blood glucose testing and monitoring further increases. Moreover, the growing awareness of the impact of diabetes on public health led to increased investments by both public and private organizations in diabetes care. For instance, Astellas Pharma recently announced a partnership with Roche Diabetes Care Japan Co., Ltd. in March 2023. The collaboration aims to develop and commercialize the Accu-Chek Guide M blood glucose monitoring system by Roche Diabetes Care. This renowned system is known for its advanced accuracy. The plan is to combine this medical type with BlueStar, an innovative solution.
COVID-19 Impact
The lancet market experienced a positive impact due to the COVID-19 pandemic. The increased demand for testing during the pandemic led to a surge in sales of lancets, as they were essential for collecting blood samples for COVID-19 diagnostics. The adoption of telemedicine and home healthcare solutions further drove the demand for lancets, enabling remote monitoring and self-testing at home. The emphasis on safety and hygiene increased the preference for single-use disposable lancets. Moreover, the pandemic stimulated research and development activities in the lancet industry, resulting in innovative advancements in lancet technologies.
Lancet Market Trends
Increasing technological advancements are predicted to accelerate the business development owing to manufacturers introducing innovative features and designs to improve lancet performance, safety, and user experience. For instance, one significant advancement is the development of lancets with ultra-thin needles, such as the BD Nano 4mm lancets by Becton, Dickinson, and Company (BD). These lancets feature a 32-gauge ultra-thin needle, reducing pain and discomfort during blood sampling, especially for blood glucose monitoring. Integrated safety features, such as retractable needles or shields, have further enhanced safety for both healthcare professionals and patients. Moreover, lancet devices are being integrated with digital health solutions, allowing for seamless data capture and analysis. These technological advancements have driven increased adoption of lancets and expanded their use across various healthcare settings.
Lancet Market Analysis
The lancet market by type is categorized into safety lancets, standard lancets, manually activated lancets, and automatically activated lancets. The manually activated lancets segment is further subdivided into push button lancets and side button lancets. The standard lancets segment garnered USD 409.6 million revenue size in 2022.
Standard lancets are widely recognized and familiar to both healthcare professionals and patients due to their well-established usage. Their compatibility and interchangeability with various lancet devices make them convenient to use. Moreover, standard lancets are affordable and cost-effective, making them accessible to a wide range of healthcare providers and patients. Their diverse applications and regulatory approvals further contribute to their market dominance.
Based on size, the lancet market is segmented into 22G and below, 23G-33G, and above 33G. The 23G-33G segment accounted for over 42% market share in the year 2022 due to their versatility, optimal balance of comfort and blood volume, clinical recommendations, user preference, and market availability. These lancets are compatible with various lancet devices and widely used for glucose monitoring and other diagnostic procedures. Their thinner needles reduce pain while ensuring adequate blood volume for accurate testing. For instance, the FreeStyle Lancets by Abbott Laboratories are crafted from sterilized stainless steel with a very thin 28-gauge design, ensuring a safe and comfortable lancing experience. Additionally, clinical guidelines and standards often specify lancets within 23G-33G range.
Based on end-use, the lancet market is segmented into hospitals, clinics, homecare settings, ambulatory surgical centers, and others. The hospitals segment accounted for over 29% market share in the year 2022. Hospitals have a large patient pool and offer a diverse range of healthcare services, Including critical care and disease management. They possess advanced infrastructure, adhere to stringent quality and safety standards, and employ skilled healthcare professionals. Lancets are extensively used in hospitals for blood sampling and diagnostics, particularly in critical care and disease monitoring.
U.S. lancet market accounted for USD 428.3 million revenue size in 2022. U.S. has a large and advanced healthcare industry, providing a conducive environment for the utilization of lancets. For instance, in 2020, the Centers for Disease Control and Prevention (CDC) reported that diabetes affected over thirty-four million Americans, accounting for approximately 11% of the U.S. population. Furthermore, the U.S. witnesses around 1.5 million new cases of diabetes each year. With a high prevalence of chronic diseases such as diabetes, lancets are in high demand for regular blood glucose monitoring in the U.S.
Furthermore, the U.S. is known for its continuous technological advancements and innovations in healthcare, including the development of advanced lancet technologies and integration with digital health solutions. The robust healthcare reimbursement system in the U.S. facilitates patient access to lancets and related healthcare services. Additionally, the emphasis on point-of-care testing further drives the demand for lancets across various healthcare settings.
Lancet Market Share
Some of the eminent market participants operating in the lancet market include
Lancet Industry News:
Lancet market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Type (USD Million & Units)
By Size (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →